Photo credits: l i g h t p o e t / BigStock
Horizon Europe’s partnership for antimicrobial resistance (AMR) research was launched last week, marking a significant step forward in combating this global health threat. The initiative aims to bring Europe closer to discovering new antimicrobial therapies within the next decade.
Compared to its predecessor under Horizon 2020, this partnership places a stronger emphasis on innovation. The goal is to accelerate the development of breakthrough solutions that can effectively address AMR challenges and improve patient outcomes.
As antimicrobial resistance continues to rise worldwide, this focused effort highlights Europe’s commitment to fostering cutting-edge research and collaboration in the fight against resistant infections. Stay tuned for more updates on how this partnership will shape the future of AMR treatment and prevention.
https://sciencebusiness.net/news/r-d-funding/antimicrobial-resistance/horizon-europes-new-antimicrobial-resistance-partnership-looks
